39 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp07599 | Tritrp-Agb | V(Agb)(Agb)FPWWWPFL(Agb)(Agb) | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 9.6 μM |
| dbacp07600 | Tritrp-hArg | V(hArg)(hArg)FPWWWPFL(hArg)(hArg) | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 13.3 μM |
| dbacp07601 | Tritrp-Lys | VKKFPWWWPFLKK | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 11.5 μM |
| dbacp07602 | Tritrp-Dap | V(Dap)(Dap)FPWWWPFL(Dap)(Dap) | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 ≥ 65 μM |
| dbacp07603 | Tritrp-Dab | V(Dab)(Dab)FPWWWPFL(Dab)(Dab) | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 ≤ 6.5 μM |
| dbacp07604 | Tritrp-Orn | V(Orn)(Orn)FPWWWPFL(Orn)(Orn) | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 ≤ 6.5 μM |
| dbacp07605 | Tritrp-P59A | VRRFAWWWAFLRR | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 12.5 μM |
| dbacp07606 | Tritrp-P59A-Lys | VKKFAWWWAFLKK | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 27.6 μM |
| dbacp07607 | Tritrp-P5A | VRRFAWWWPFLRR | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 16.2 μM |
| dbacp07608 | Tritrp-P5A-Lys | VKKFAWWWPFLKK | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 27.6 μM |
| dbacp07609 | Tritrp-P9A | VRRFPWWWAFLRR | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 6.8 μM |
| dbacp07610 | Tritrp-P9A-Lys | VKKFPWWWAFLKK | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 15.1 μM |
| dbacp07611 | Tritrp-W678F | VRRFPFFFPFLRR | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 24.6 μM |
| dbacp07612 | Tritrp-W678bTA | VRRFP(bTA)(bTA)(bTA)PFLRR | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 9.6 μM |
| dbacp07613 | Tritrp-W6hW | VRRFP(hW)WWPFLRR | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 16.1 μM |
| dbacp07614 | Tritrp-W7hW | VRRFPW(hW)WPFLRR | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 15.1 μM |
| dbacp07615 | Tritrp-W8hW | VRRFPWW(hW)PFLRR | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 10.7 μM |
| dbacp07616 | Tritrp-W789hW | VRRFP(hW)(hW)(hW)PFLRR | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 44.8 μM |
| dbacp07617 | Tritrp-W6A | VRRFPAWWPFLRR | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 36.5 μM |
| dbacp07618 | Tritrp-W7A | VRRFPWAWPFLRR | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 48.2 μM |
| dbacp07619 | Tritrp-W8A | VRRFPWWAPFLRR | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 22.8 μM |
| dbacp07620 | Tritrp-W67A | VRRFPAAWPFLRR | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 ≥ 65 μM |
| dbacp07621 | Tritrp-W68A | VRRFPAWAPFLRR | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 ≥ 65 μM |
| dbacp07622 | Tritrp-W78A | VRRFPWAAPFLRR | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 ≥ 65 μM |
| dbacp07623 | Tritrp-W678A | VRRFPAAAPFLRR | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 ≥ 65 μM |
| dbacp07624 | Tritrp-W6Y | VRRFPYWWPFLRR | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 19.3 μM |
| dbacp07625 | Tritrp-W7Y | VRRFPWYWPFLRR | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 11.4 μM |
| dbacp07626 | Tritrp-W8Y | VRRFPWWYPFLRR | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 12.0 μM |
| dbacp07627 | Tritrp-W67Y | VRRFPYYWPFLRR | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 32.2 μM |
| dbacp07628 | Tritrp-W68Y | VRRFPYWYPFLRR | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 35.4 μM |
| dbacp07629 | Tritrp-W78Y | VRRFPWYYPFLRR | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 25.6 μM |
| dbacp07630 | Tritrp-W678Y | VRRFPYYYPFLRR | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 ≥ 65 μM |
| dbacp07631 | Tritrp DiSu | CVRRFPWWYPFLRRC | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 12.3 μM |
| dbacp07632 | MagaininF5W-Lys | GIGKWLHSAKKFGKAFVGEIMNS | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 16.8 μM |
| dbacp07633 | MagaininF5W-Arg | GIGRWLHSARRFGRAFVGEIMNS | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 16.8 μM |
| dbacp07634 | PuroA-Arg | FPVTWKWWKWWKG | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 10.0 μM |
| dbacp07635 | PuroA-Lys | FPVTWRWWRWWRG | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 12.0 μM |
| dbacp07636 | Indolicidin-Lys | ILPWKWPWWPWKK | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 9.5 μM |
| dbacp07637 | MPG | GALFLGFLGAAGSTMGAWSQPKKKRKV | Synthetic | Membrane permeabilization via lysine substitution | MTT assay | Jurkat | Blood Cancer | IC50 = 15.8 μM |